[podcast]AstraZeneca’s Arun Krishna says Tagrisso-based combo promises new option in lung cancer

Jack O’Brien interviews AstraZeneca’s Arun Krishna about a Tagrisso-based combo that promises a new option in lung cancer. Plus, updates on the new NIH director and the latest TikTok trend.